63 related articles for article (PubMed ID: 7563656)
1. [Long term/intermittent treatment of chronic hepatitis C with recombinant interferon alfa-2b].
Hakozaki Y; Fujioka T; Katou M; Kondo T; Oba K; Nakagawa K; Shirahama T
Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):1001-6. PubMed ID: 7563656
[No Abstract] [Full Text] [Related]
2. Treatment of chronic hepatitis B and hepatitis C with interferon alfa-2b.
Molloy PJ; Azzouz M; Van Thiel DH
Am Fam Physician; 1996 Oct; 54(5):1598-605. PubMed ID: 8857782
[TBL] [Abstract][Full Text] [Related]
3. [Interferon treatment for chronic hepatitis C--assessment of 3 regimens in patients received more than 500 MU interferon treatment and their effect predictive factors for interferon treatment using multivariate analysis with the logistic regression model].
Terada M
Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):1007-11. PubMed ID: 7563657
[No Abstract] [Full Text] [Related]
4. Long-term interferon alfa-2b retreatment of relapsing patients with chronic hepatitis C.
Picciotto A; Sinelli N; Brizzolara R; Campo N; Lapertosa G; Celle G
J Hepatol; 1997 Feb; 26(2):447-8. PubMed ID: 9059973
[No Abstract] [Full Text] [Related]
5. [Efficacy of interferon re-therapy and its adaptation in chronic hepatitis C].
Matsuo S; Ohnishi K; Fujiwara K
Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):1012-6. PubMed ID: 7563658
[No Abstract] [Full Text] [Related]
6. Prevalence of breakthrough in chronic hepatitis C patients undergoing antiviral therapy: role of type and schedule of alpha interferon C.H.S.G.
Bellati G; Colloredo G; Roffi L; D'Aquino M; Bonino F; Idéo G
J Hepatol; 1997 Feb; 26(2):449-50. PubMed ID: 9059974
[No Abstract] [Full Text] [Related]
7. Experts recommend longer treatment for hepatitis C virus.
Roper CR; Ford D
AORN J; 1995 Sep; 62(3):358. PubMed ID: 8534054
[No Abstract] [Full Text] [Related]
8. [How should hepatitis C be treated? Treatment of hepatitis C with interferon].
Marcellin P
Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S81-8. PubMed ID: 9161518
[No Abstract] [Full Text] [Related]
9. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience.
Schvarcz R; Ando Y; Sönnerborg A; Weiland O
J Hepatol; 1995; 23 Suppl 2():17-21. PubMed ID: 8720289
[TBL] [Abstract][Full Text] [Related]
10. [Recombinant alpha 2b interferon in the treatment of chronic viral hepatitis C: comparison of 2 schemes, classical and high-dosage].
Polus M
Rev Med Liege; 1995 May; 50(5):226-9. PubMed ID: 7784752
[No Abstract] [Full Text] [Related]
11. Efficacy of interferon alpha in acute hepatitis C in patients on chronic hemodialysis.
Süleymanlar I; Sezer T; Işitan F; Yakupoglu G; Süleymanlar G
Nephron; 1998; 79(3):353-4. PubMed ID: 9678442
[No Abstract] [Full Text] [Related]
12. Interferon and steroid treatment in patients with chronic hepatitis C and antinuclear or anti-liver-kidney microsomal antibodies.
Provenzano G; Almasio P; Fabiano C; Magrin S; Pinzello G; Vaccaro A; Craxì A
Ital J Gastroenterol; 1996 Sep; 28(7):377-80. PubMed ID: 8937938
[TBL] [Abstract][Full Text] [Related]
13. Lack of sustained efficacy of interferon in patients with chronic hepatitis C.
Vento S; Concia E; Ferraro T
N Engl J Med; 1996 May; 334(22):1479-80. PubMed ID: 8618600
[No Abstract] [Full Text] [Related]
14. Interferon alfa-2b for decompensated liver disease caused by either chronic hepatitis B or C: preliminary results of a pilot study.
Dimopoulou M; Fafoutis K; Basiliou K; Ketikoglou J; Karvountzis G
Gut; 1993; 34(2 Suppl):S104-5. PubMed ID: 8314470
[TBL] [Abstract][Full Text] [Related]
15. [Two cases of acute exacerbation of chronic hepatitis C improved after the administration of an immunosuppressive drug and interferon].
Ikeda H; Nishina K; Asatani Y; Yumoto E; Okano N; Seno H; Yamano T; Kiyono T; Konishi A; Inoue T
Nihon Shokakibyo Gakkai Zasshi; 1995 Aug; 92(8):1200-5. PubMed ID: 7563929
[No Abstract] [Full Text] [Related]
16. Therapy in chronic hepatitis C: say goodbye to the 6-month interferon regimen.
Koff RS
Am J Gastroenterol; 1996 Oct; 91(10):2072-4. PubMed ID: 8855723
[No Abstract] [Full Text] [Related]
17. [Efficacy of interferon combined glycyrrhizin therapy in patients with interferon-resistant chronic hepatitis C].
Okuno T; Arai K; Shindo M
Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):1022-5. PubMed ID: 7563661
[No Abstract] [Full Text] [Related]
18. [Current knowledge in the treatment of chronic hepatitis C].
Pirotte J
Rev Med Liege; 1995 Dec; 50(12):501-4. PubMed ID: 8570988
[No Abstract] [Full Text] [Related]
19. Hepatitis C: limits and dose regimen of interferon alfa.
Prescrire Int; 1998 Oct; 7(37):150-4. PubMed ID: 10915423
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon-alpha 2b.
Saracco G; Rosina F; Abate ML; Chiandussi L; Gallo V; Cerutti E; Di Napoli A; Solinas A; Deplano A; Tocco A
Hepatology; 1993 Dec; 18(6):1300-5. PubMed ID: 7694894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
